Body Size Regulation via BMP Signaling in \u3ci\u3eCaenorhabditis elegans\u3c/i\u3e by Madaan, Uday
City University of New York (CUNY) 
CUNY Academic Works 
All Dissertations, Theses, and Capstone 
Projects Dissertations, Theses, and Capstone Projects 
6-2017 
Body Size Regulation via BMP Signaling in Caenorhabditis 
elegans 
Uday Madaan 
The Graduate Center, City University of New York 
How does access to this work benefit you? Let us know! 
More information about this work at: https://academicworks.cuny.edu/gc_etds/2084 
Discover additional works at: https://academicworks.cuny.edu 






BODY SIZE REGULATION VIA BMP 















A dissertation submitted to the Graduate Faculty in Biology in partial fulfillment of the 



















































All Rights Reserved 
	   	  iii	  





This manuscript has been read and accepted for the Graduate Faculty in Biology in 




___________________ ______________________________________________     
Date  Chair of Examining Committee 
   Dr. Cathy Savage-Dunn, Queens College 
 
___________________ ______________________________________________     
Date  Executive Officer 
   Dr. Laurel A. Eckhardt 
 
 
   ______________________________________________  
   Dr. Daniel Weinstein, Queens College 
 
 
   ______________________________________________   
   Dr. Paul G. Feinstein, Hunter College 
 
 
   ______________________________________________  
                                                   Dr. Chris Li, City College 
 
 
   ______________________________________________ 
   Dr. Christine A. Rushlow, New York University 
    
       
    
   
 
   
 
      
Supervising Committee 
 
       The City University of New York 
 
	   	  iv	  
 
ABSTRACT 




Advisor: Dr. Cathy Savage-Dunn 
The body size of an organism can be a crucial determinant of access to nutrition, 
reproductive success and overall survival in the wild. However, how body size of an 
individual is determined is incompletely understood. Body size is a complex trait 
determined by multiple pathways and genes, making it difficult to understand the role of 
individual genes and pathways in determining overall size. In Caenorhabditis elegans, a 
homolog of Bone Morphogenetic Proteins (BMP) is a major regulator of body size; 
functional loss of DBL-1 leads to a small body size. Due to a drastic change in body size 
in dbl-1 mutants, we have the advantage of studying body size as a monogenic trait and 
we are able to investigate the upstream and downstream factors involved in body size 
regulation. During the course of our investigation, we identified cuticle collagen genes as 
hypodermal transcriptional targets of DBL-1 signaling that act as effectors of body size 
regulation. We have identified positive (col-41), negative (col-141, co-142), and dose-
sensitive regulators (rol-6) of body size. In Yin et al. (2014) we performed promoter 
dissection to define sequences necessary for col-41 expression, we further showed a 
GATA factor elt-1, regulates col-41 expression. Next, I have shown cuticle collagens are 
directly and indirectly regulated, using chromatin immunoprecipitation followed by high 
throughput sequencing (ChIP-Seq). Furthermore, I have shown Smad binding to 
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conserved Smad Binding Elements (SBE) in a common promoter region for col-141 and 
col-142 and demonstrated that SBE in this region are required for gene expression. 
Utilizing electrophoretic mobility shift assays (EMSA), I showed functional conservation 
of Smads in C. elegans via strong and specific SMA-4 binding to GTCT (Smad Binding 
Element) sites. I have discovered a stage specific requirement of Smads for expression of 
cuticle collagen genes. Based on our work we emphasize that cuticle collagens are the 
effectors of body size regulation via the DBL-1 pathway. Lastly, utilizing transcriptional 
and translation reporters we show that inhibition of col-41, rol-6, col-141, and col-142 
affects DBL-1 transcription. Hence, we have provided first evidence of a feedback loop 
between the cuticle and DBL-1 signaling.  
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Introduction 
I.1 The TGF-β  Pathway 
The Transforming Growth Factor-β (TGF-β) superfamily encompasses more than 
30 ligands including BMP, Activin, and Nodal. TGF-β signaling is highly conserved 
across the evolutionary scale along with the components of its pathway1. The TGF-β 
superfamily of ligands is involved in several critical developmental processes beginning 
at embryonic development and continuing through out adulthood. Defects in the TGF-β 
pathway are associated with cancer, fibrosis, and Marfan syndrome among many other 
diseases.  
The basic components required for signaling, which include the type I and type II 
Serine/Threonine kinase receptors and the signal transducers Smads, are highly 
conserved across the evolutionary scale. BMPs are part of the TGF-β family and are also 
critical for a number of processes such as cell differentiation, bone formation, heart 
development etc2. TGF-β signaling starts with the binding of the ligand to the tetrameric 
type I and type II receptor complex3. The type II receptor is constitutively active and 
upon binding of the ligand, the type II receptor phosphorylates and activates the type I 
receptor4. The R-Smads can now associate with the type I receptor and are 
phosphorylated at their C-terminus at the SXS/T motif. Phosphorylation of the R- Smads 
is necessary for interaction with co-Smads (common mediator Smads) and response to 
TGF-β signaling 5 6,7. Smads typically have a MH1 (Mad Homology 1, DNA binding 
domain) and a MH2 (Mad Homology 2, protein interaction domain) with a linker region 
in between the two domains (Figure 1). Without phosphorylation the MH1 and MH2 
domain are in a conformation such that DNA binding is prevented and the Smads 
	   	  2	  
constantly shuttle back and forth between the nucleus and the cytosol. Phosphorylation 
leads to conformation change and allows for complex formation between the R-Smads 
and Co-Smads and subsequent retention/accumulation in the nucleus 8-10 where Smads 
act as transcription factors and regulate pathway target genes. 5-­‐9,11-­‐16. The structure of 
Co-Smad has a NES (nuclear export signal) between its MH1 domain and the linker 
region. The complex of R-Smads and Co-Smad masks the NES allowing Co-Smad to 
accumulate in the nucleus to regulate target genes of the pathway. Smads are known to 
bind a 4bp GTCT Smad Binding Element (SBE); furthermore, R-Smads for BMP ligands 
associate with GC-rich sequences (GGAGCC, GGCGCC, termed GC-SBE) 17-19,20,21.  
 
Figure 1: Structure of Smads.  All 3 Smads have a DNA binding domain and a protein 
interaction domain. SMA-2, SMA-3 is the R-Smads phosphorylated by type I receptor, SMA-4 is the Co-
Smad.  
 
In C. elegans, there are 5 TGF-β orthologs: DBL-1, DAF-7, UNC-129, TIG-2, 
and TIG-3. DBL-1 is the homolog of BMP2/4 and signals through SMA-6 type I and 
DAF-4 type II receptor. The formation of the receptor-ligand complex leads to 
phosphorylation of the R-Smads (SMA-2, SMA-3) and formation of a heterotrimer 
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complex with Co-Smad (SMA-4). The heterotrimer complex can now accumulate in the 
nucleus to regulation target genes of the pathway (Figure 2).  
TGF-β signaling is present in multiple cell and tissue types, however there are 
differences in the induced gene profile in different cells via the same signaling. Since the 
basic components of signaling are the same in all cells, why are different gene profiles 
observed via the same signaling in a context dependent manner? A possible way to 
account for context dependent gene regulation is Master transcription factors (MTFs), 
which are transcription factors necessary for cell fate. MTFs are also called pioneer 
transcription factors because MTFs can actively open the chromatin at nucleosome sites 
allowing other transcription factors to bind to the now loose chromatin and activate 
genes22,23. MTFs can specifically recruit Smads to adjacent binding sites in response to 
TGF-β signaling and activate genes in a tissue specific manner. In embryonic stem cells, 
core transcription factors (Nanog, Oct4, Sox2) necessary for maintaining pluoripotency 
recruit Smads to target genes in response to TGF-β signaling 24. Furthermore, the 
regenerative response to BMP and WNT signaling was coupled to master regulators 
GATA1, GATA2, C/EBPα necessary for erythroid, progenitor, and myeloid cell 
differentiation respectively25.  It was further shown that TGF-β signaling regulated genes 
bound by cell-type specific MTFs. MTFs can provide a possible mechanism for cell-type 
specific responses initiated by TGF-β signaling.  
I.2 Extracellular Regulation of BMP Signaling 
There are multiple levels of BMP signaling regulation; intracellular regulators are 
the phosphorylation state of the Smads and downstream co-factors required for gene 
expression. Extracellular regulation is critical for bioavailability of growth factors and 
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signal initiation. In C. elegans, multiple transmembrane proteins such as CRM-1, LON-2, 
SMA-10, and DRAG-1 tightly regulate DBL-1 binding to its receptors. LON-2, a heparin 
sulfate proteoglycan, is a negative regulator of DBL-1 and lon-2 mutants are long in body 
size26. SMA-10 is an extracellular positive regulator of body size; it belongs to the LRIG 
(Leucine rich repeats and immunoglobin-like domains) family of extracellular 
transmembrane proteins. SMA-10 enhances DBL-1 signaling by binding SMA-6 and 
DAF-4, the type I and type II receptors respectively27. Homologs of LRIG in Drosophila 
have unknown functions, the Drosophila homolog can rescue SMA-10 mutants27. 
DRAG-1 is a member of the RGM (Repulsive Guidance Molecules) family and acts at 
the receptor/ligand level to positively regulate DBL-1 signaling and its role in body size 
and mesodermal patterning28,29. CRIM-1 belongs to the cysteine rich motor-neuron 
(CRIM) protein family, CRIM-1 is expressed in ventral nerve cord and acts non-
autonomously to facilitate DBL-1 signaling30. However, in vertebrates CRIM-1 acts as an 
antagonist by affecting BMP processing and release from the cell.31 Lastly, an ADAMTS 
metalloprotease family member, ADT-2 (sma-21) promotes DBL-1 signaling activity and 
is required for normal cuticle structure32.  
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Figure 2. BMP Signaling In C. elegans. DBL-1 the homolog of BMP2/4 in C.elegans binds SMA-6 and 
DAF-4 receptors that phosphorylate SMA-2, SMA-3 allowing for complex formation with SMA-4. This 
heterotrimer is now shuttled and accumulated in the nucleus.  
 
In vertebrates, antagonists such as Noggin, Grem1, and Chordin regulate BMP 
signaling extracellularly. Grem1, Noggin, and Chordin directly bind BMP homodimers to 
prevent association with BMP receptors33. Members of the RGM family RGMa, RGMb, 
and RGMc are required for BMP2 and BMP12 signaling by direct binding to BMP 
ligands and promoting interaction with BMP receptors. Loss of RGMa, RGMb, and 
RGMc, decreased response to BMP2 and BMP12 signaling34. Additional levels of 
regulation are provided by the ECM, which plays a central role in extracellular regulation 
by inhibiting and promoting BMP signaling. In Drosophila, the role of collagen type IV 
in regulation of BMP signaling has provided key insights. For instance, collagen type IV 
provides a scaffold for the complex of short gastrulation (Sog), twisted gastrulation (Tsg) 
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and Dpp (homolog of BMP). Sog and Tsg are cleaved by tolloid metalloproteinase, 
collagen type IV allows for this cleavage and release of Dpp at distance35. Sog is 
homologous to xenopus Chordin (antagonist of BMP) and can also act as an antagonist by 
binding Dpp in the neuroectoderm during embryonic development36. 
In mammals and cell culture, the role of other ECM components has been 
explored. For instance, hyaluronic acid (HA) a glycosaminoglycan that exists as a free 
polysaccharide in the ECM is required for CD44 (cell surface receptor) clustering. CD44 
interacts with Smad1 to promote response to BMP7. In absence of HA decreases BMP7 
induced phosphorylation of Smad1 in murine chondrocytes37-39. The N-terminal 
prodomain of BMP-2 is bound by collagen type IIA and the C-terminal of BMP4 is 
bound by collagen type IV, to promote gradient formation and promote binding to 
receptors40,41. Cartilage oligomeric matrix protein (COMP), an ECM glycoprotein, assists 
in complex formation between proteogylcans and collagens, this prevents endocytosis of 
the BMP receptor complex allowing for continuous signaling42. However, COMP has 
also been shown prevent BMP-2 signaling by direct binding to the C-terminal and 
preventing association with the receptor43. The role of COMP is likely context dependent 
and requires further work. Biglycan a member of the small-leucine rich proteogylcans 
(SLRP) can inhibit and promote BMP signaling in a context dependent manner. Biglycan 
promotes binding of Chordin to BMP4 to inhibit signaling, however, biglycan has also 
been shown to promote BMP2 signaling in in vitro44-47.  
I.3 Trafficking And Internalization Of BMP Ligands And Receptors 
 Trafficking and recycling of signaling receptors is an important step in regulation 
of signal propagation and duration. Internalization of cell surface receptors happens in a 
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clatherin-mediated and clatherin-independent manner; internalization separates the 
receptors away from the plasma membrane and its micro-domains. Endocytosis of 
receptors can lead to multiple outcomes: 1) The signal complex is recycled back to the 
plasma membrane leading to further signaling. 2) Signal termination through lysosomal 
degradation of the receptor/ligand complex or the receptors only. 3) The activated 
ligand/receptor complex is internalized into signaling endosomes and continues signal 
propagation48,49. Work in mammalian cells lines shows TGF-β receptors are largely 
internalized through clathrin mediated endocytosis, however receptor endocytosis is not a 
requirement for downstream Smad activation and nuclear localization50. Largely, BMP 
receptor endocytosis occurs in a clathrin-dependent manner analogous to TGF-β 
receptors. BMP receptors interact with caveolin and localize to cholesterol rich 
microdomains for activation of non-canonical signaling51. In C. elegans, internalization 
of TGF-β family receptors through a clathrin-mediated pathway is observed52. The type I 
receptor is not internalized and is recycled to the membrane through a retromer. 
Meanwhile, the type II receptor is internalized and recycled to the surface for additional 
signaling53.   
I.4 Body Size and Growth Regulation 
DBL-1 is a major regulator of body size, and is also involved in mail tail 
patterning, innate immunity, and mesodermal patterning. DBL-1 is the homolog of 
BMP2/4 and it is secreted from neurons in the head and the ventral nerve cord. 
Components of DBl-1 signaling such as the signaling transducers SMA-2, SMA-3, and 
SMA-4 are present in the hypodermis, intestine, and the pharynx. Presence of SMA-3 in 
the hypodermis tissue is necessary and sufficient for normal body size54. DBL-1 is a 
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dose-dependent regulator of body size: dbl-1 homozygous mutants are small in body size, 
heterozygous worms have an intermediate body size, and overexpression of DBL-1 leads 
to a longer body size. The change in body size is due to a change in cell size and tissue 
volume rather than a change in cell number. Furthermore, different tissues are reduced in 
different proportions; hypodermis is reduced proportionately to the small body size55. For 
normal body size the source of DBL-1 is not relevant as long as a normal levels of 
DBL-1 expression is present56.  
In Drosophila, body size is regulated on three levels: genes that slow down 
growth (minute), genes that affect organ growth, and genes that regulate overall body and 
organ size (diminutive). Chico a homolog of IRS proteins is involved in the MPK 
pathway, which activates PI3K and ultimately regulates insulin signaling, mutations in 
chico lead to a small cell and body size. Mutations in Drosophila homolog of IGF-I 
receptor, result in smaller flies with a decreased cell number. Hence, the role of insulin 
signaling is to regulate overall growth and size of Drosophila57. The JAK/STAT pathway 
is involved in organ size regulation via maintaining cell populations necessary for Dpp 
expression58. Additionally, the Dpp pathway has been implicated in cell proliferation and 
also in organ size, as seen in wing development59.  
Genome wide association (GWA) studies in humans have implicated several 
classes of genes leading to minor changes in body size including: growth factors 
pathways involved in skeletal growth (GDF5), regulators of agonists and antagonists of 
growth factors (STC2), genes involved in ECM remodeling (ADAMTS), and cell cycle 
genes (CDK6) among others. Alleles associated with implicated genes lead to changes of 
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up to 2.1 cm in height60,61. How these genes lead to changes in height is unclear and 
requires further work.  
I.5 C. elegans Life Cycle 
Caenorhabditis elegans was established as a model organism by Sydney Brenner 
in 196362. C. elegans is a translucent free living worm; it is one of the most abundant 
organisms on the planet often found in soil. In the laboratory setting, C. elegans is grown 
at 20°Celsius on agar plates and fed Escherichia coli and reaches adulthood from its 
embryonic stage in 4 days. In case of starvation conditions due to lack of a food supply, 
the nematode enters an alternative dauer stage. C. elegans can survive in this quiescent 
dauer stage for extended periods of time (~ 4 months). C. elegans has males (XO) and 
hermaphrodites (XX) as its two sexes. It has about 1000 somatic cells, out of which 302 
are neurons.  There are four developmental larval stages (L1, L2, L3, and L4) followed 
by adult stage. At the end of each larval stage the outer exoskeleton of the worm, termed 
the cuticle, molts.  
I.6 The Hypodermis	  
The underlying hypodermis tissue secretes the cuticle, a protective collagenous 
extracellular matrix composed of glycoproteins, lipids and collagens63. The hypodermis is 
a multinucleate syncytium (hyp1-7, 10, and 13) with hyp7 as the largest with 139 nuclei; 
hyp7 covers almost all the body length of the worm. The hypodermis is differentiated 
from three cell lineages: the AB embryonic founder cells, the seam cells and the ventral 
blast cells (P cells) 64. Besides secreting the cuticle, the hypodermis provides storage for 
nutrients, provides a body plan, is involved in cell migration and specification of 
neighboring cells65. The hypodermis behaves as a major signaling hub, expression of 
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SMA-3 in the hypodermis is necessary and sufficient for normal body size54, necessary 
for fat storage, and necessary for innate immune response (M. Meade, E. Ciccarelli, 
personal communications).   
I.7 The Cuticle 
The cuticle is the exoskeleton of the worm, it provides protection against the 
environment, pathogens, maintains body shape and allows for motility. The hypodermal 
cells, the interfacials cells lining the anus, excretory pore, vulva and pharynx, secrete the 
cuticle. The cuticle is shed at the end of each larval stage post lethargus, which is the 
period of no activity before the cuticle shedding. The new cuticle layers are secreted 
beneath the old existing cuticle. The adult cuticle is composed of five layers, the surface 
coat, the epicuticle layer, the cortical, medial and basal zones66. The larval cuticle is 
different in types of layers present or their thickness compared to the adult cuticle. 
Furthermore, the composition of each cuticle is different based on the specific cuticle 
collagens expressed during a particular larval stage67.  A main component of the cuticle, 
are the cuticle collagens, which, are regulated by multiple signaling pathways such as 
insulin, Wnt and DBL-1 signaling68-70.  
I.8 Collagens 
The collagen superfamily of proteins is a main component of dense connective 
tissue and provides structural support for the extracellular matrix and various cell types. 
Collagens constitute ~30% of the protein mass in humans and are the most abundant 
protein. Collagens function in a diverse range of processes such as mechanical properties 
of tissue, ligands for receptors, cell growth, differentiation, cell migration, bone 
formation, skeletogenesis and the integrity and function of the epidermis71-73.  There are 
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28 different types of collagens and 45 known vertebrate collagen genes; invertebrates 
have their own set of collagens74. All collagen molecules are formed with three 
polypeptide α chains, all chains contain repeats of Gly-X-Y sequences. The α chain 
trimers in some collagen molecules can be different (heterotrimers) such as α1 or α2 
chains or they can be similar (homotrimers). The chains are coded by different genes and 
only chains from the same genes form trimers.  The α chains coil together into a left-
handed helix around a common axis to form a triple helix. The presence of Glycine in 
every third position in the Gly-X-Y repeats is essential for the triple helix formation and 
mutations in the glycine residues tend to be more severe than at other residues. For 
instance, replacement of the glycine residue with another amino acid leads to 
osteogenesis imperfecta, a connective tissue disorder, with deformities of long bones, 
growth deficiency and fractures from mild trauma75.  
 
 
Figure 3. Cuticle Collagen Structure. Gly-X-Y repeats are characteristic of all collagens and collagen-
like molecules. Cuticle collagens belong to FACIT type collagens due to the interruptions in Gly-X-Y 
repeats of other amino acids in their triple helices. 
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Generally, mutations on the C-terminal glycine tend to produce more severe 
phenotypes than similar mutations on the N-terminal glycines, likely because the triple 
helix of most collagens is propagated from the C-terminus to N-terminus76. The triple 
helix has regions of high and low stability result of amino acids present at the X-Y 
position of Gly-X-Y repeats; hence mutations in different regions have variable effects. 
Mutations that alter collagen polypeptides such that they can still interact with other 
chains lead to harsher phenotypes, relative to mutations interrupting trimer formation or 
null mutations 77-79. Largely mutations in collagens leading to diseases have been 
recognized in rare heritable diseases such as osteogenesis imperfecta, several subtypes of 
Ehlers-Danlos syndrome, various chondrodysplasias, X-linked forms of Alport 
syndrome, Bethlem myopathy, Ullrich muscular dystrophy, corneal endothelial 
dystrophy, and Knobloch syndrome76.  
 
I.8.1 C. elegans Collagens 
C. elegans has two major types of collagens-the basement membrane collagens 
and the cuticle collagens. The basement membrane collagens are homologues of two 
vertebrate type collagens, a type IV, heterotrimer made of α1(IV) and α2(IV) chains and 
a type XVIII homotrimer, [α1(XVIII)]380. Mutations in either of the two type IV basement 
membranes are embryonically lethal81 while mutations in type XVIII result in cell and 
axon migration defects and cause defects in neuromuscular junction organization80,82. 
 The cuticle collagens closely resemble the vertebrate fibrillar associated collagens with 
interrupted triple helices (FACIT) and form the exoskeleton of the worm secreted from 
the underlying hypodermis tissue. The cuticle collagens number in more than 170 genes, 
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leading to proteins ~30 kDa with the typical collagen structure with amino and carboxy 
terminal domains and the triple helix with 8-10 and 40-42 Gly-X-Y repeats83-85. 
Mutations in cuticle collagens often lead to body morphology phenotypes such as 
DumPY(Dpy), ROLler(Rol), BLIster (bli), Squat (Sqt), and Long (Lon).  
I.8.2 Collagen Processing 
Collagen is synthesized as procollagen molecules composed of an amino terminal 
propeptide, a short, nonhelical N-telopeptide, a central triple helix, a C-telopeptide and a 
carboxy-terminal propeptide. The initial procollagen goes under multiple post-
translational modifications such as glycosylation of lysine residues, hydroxylation of 
proline and lysine residues etc.76 Prolyl-4-hydroxylation of the procollagen allows it fold 
into a thermally stable form. In C. elegans DPY-18 is a critical α subunit of prolyl-4-
hydroxylase, null mutants of dpy-18 result in medium Dpy phenotype and reduce prolyl-
4-hydroxylation in cuticle collagens86,87. Following trimerization collagens are 
transported from the ER to the golgi via secretory vesicles part of the COPII pathway. 
SEC-23 is an essential component of the COPII secretory vesicles and loss of sec-23 
leads to accumulation of the cuticle collagen in the ER.  
Preceding collagen multimerization the procollagen under goes amino terminus 
and carboxy terminus cleavage, which leads to the formation of the insoluble product. In 
vertebrates the heat shock protein 47 (Hsp 47) acts as a molecular chaperone and binds 
procollagen in the endoplasmic reticulum88. Procollagens and propeptides are cleaved 
during the maturation process. The N-terminal peptides are cleaved by procollagen N-
proteinases and the C-terminal peptides are cleaved by BMP-1 (Bone Morphogenetic 
Protein 1). In C. elegans all cuticle collagens share a highly conserved N-terminal 
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cleavage site for BLI-4, this site has been shown to be necessary for processing of ROL-6 
and SQT-1 collagens. bli-4 null mutants are embryonically lethal, partial loss-of-
functions mutants are viable but have Blistered and dumpy phenotypes89-91. C-terminal 
processing is also an integral part of procollagen maturation, usually carried out by zinc 
metalloproteases of BMP class. In C. elegans, dpy-31 encodes a hypodermis specific 
procollagen C-peptidase required for normal collagen secretion92. The last step in cuticle 
synthesis and collagen maturation is structural cross-linking and the dual oxidase enzyme 
encoded by bli-3 performs this function in C.elegans. Inhibition of bli-3 lead to weakened 
cuticles lacking tyrosine cross-links, resulting in Dpy and Bli phenotypes and a cuticle 
lacking struts.  
Of the 170 collagen genes some are relegated to specific larval stages while other 
are expressed at each larval stage93. Cuticle collagens are expressed in strict temporal and 
spatial patterns and are classified as early, intermediate and late, referring to peak mRNA 
four hours prior, two hours prior and simultaneous with the secretion of the new cuticle at 
each larval stage. Cuticle collagens that are expressed at the same early stage contribute 
to the same cuticle substructure. For instance, five early expressed DPY collagens 
interact to form the narrow bands needed for the annular furrows and two intermediate 
expressing sets interact to compose the broader bands necessary for normal width of the 
annuli94. It was also shown that cuticle collagens interact with each other and disrupting 
expression of one cuticle collagen within the interacting set can affect expression of 
others in that set. 60% of cuticle collagens are expressed in a stage specific manner, while 
others are expressed at every stage, leading to functional redundancy and functional 
	   	  15	  
specificity. Therefore, a large extent of collagen mutations does not show phenotypes or 
the phenotypes are so subtle as to be undetectable.  
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PCR in sma-3 mutants at L2 and adult stages. I performed all associated work for 
creating transcriptional reporters: col-p::2xNLS::mcherry, col-141[lf(2xNLS::GFP)]. I 
guided Michael Meade in creating rol-6 OE, and col141col142 OE lines. I also 




Body size is a tightly regulated phenotype in metazoans that is dependent on both 
intrinsic and extrinsic factors. While signaling pathways are known to control organ and 
body size, the downstream effectors that mediate their effects are still poorly understood. 
In the nematode C. elegans, a Bone Morphogenetic Protein (BMP)-related signaling 
pathway is the major regulator of growth and body size. We investigated the 
transcriptional network through which the BMP pathway regulates body size and 
identified cuticle collagen genes as major effectors of growth control. Here we 
demonstrate that cuticle collagens can act as positive regulators (col-41), negative 
regulators (col-141, col-142), or dose-sensitive regulators (rol-6) of body size. Moreover, 
we show requirement of BMP signaling for stage-specific expression of cuticle collagen 
genes. We show that the Smad signal transducers directly associate with conserved Smad 
binding elements in regulatory regions of col-141 and col-142, but not of col-41. Hence, 
cuticle collagen genes are directly and indirectly regulated via the BMP pathway. Our 
work thus connects a conserved signaling pathway with its critical downstream effectors, 
advancing insight into how body size is specified. Since collagen mutations and 
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misregulation are implicated in numerous human genetic disorders and injury sequelae, 
understanding how collagen gene expression is regulated has broad implications.  
 
Introduction 
The Transforming Growth Factor-beta (TGF-β) superfamily encompasses more 
than 30 ligands including Bone Morphogenetic Proteins (BMPs), Activin, and Nodal. 
BMPs play essential roles in development and have been studied in a variety of contexts 
1. The roles of BMPs in growth and body size regulation, however, are relatively 
unexplored. This deficit is partly due to body size being expressed as a complex trait 
with continuous variation. The existence of monogenic variants with discrete body size 
changes provides us with an entry point into growth and size regulating mechanisms. 
We have capitalized on the major visible effect of BMP signaling on growth regulation 
in the nematode Caenorhabditis elegans to uncover transcriptional targets acting as 
effectors of body size regulation.  
BMPs are highly conserved among animal species along with the components of 
their signaling pathways. BMP homologs are present in Drosophila (e.g. 
Decapentaplegic (Dpp)) and C. elegans (e.g. Dpp/BMP-like-1 (DBL-1)) 1, genetically 
tractable organisms in which Smads, the intracellular components of the TGF-β 
signaling pathway, were first identified 95,96. Receptor-regulated Smads (R-Smads) are 
directly phosphorylated by the TGF-β receptors on the C-terminus. This allows 
formation of the heterotrimeric Smad complex with co-Smads that accumulates in the 
nucleus to regulate target genes of the pathway 5-9,11-16. Smads are known to bind a 4 bp 
GTCT Smad Binding Element (SBE); furthermore, R-Smads for BMP ligands associate 
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with GC-rich sequences (GC-SBE) 17-19.  While much detailed knowledge has been 
obtained in studies of a few direct Smad target genes, fewer studies have addressed the 
direct and indirect transcriptional programs required to mediate biological functions in 
intact organisms.  
In C. elegans, the DBL-1/BMP signaling pathway is the major regulator of 
growth and body size. DBL-1 ligand is secreted by neurons and body wall muscle, and 
is necessary for body size regulation and other developmental and homeostatic processes 
97. The small body size phenotype is the result of a reduction in cell size rather than cell 
number. Previous work has pinpointed the hypodermis, the outermost multinucleated 
epithelium, as the main target tissue of DBL-1 signaling. In dbl-1 mutants, different 
tissue sizes are reduced to different extents, with hypodermal tissue reduced in 
proportion to body size 55. Furthermore, we have previously shown by tissue-specific 
expression of SMA-3 (R-Smad) in a sma-3 mutant background that activation of the 
DBL-1 pathway in the hypodermis is necessary and sufficient for normal body size 54. 
Similar conclusions have been drawn in experiments with the DBL-1 receptors 98,99. To 
identify the transcriptional targets of the DBL-1 pathway that may function in body size 
regulation, we performed microarray analysis on dbl-1 mutants 70. The functions of 
putative target genes were analyzed by RNA interference (RNAi) knockdowns, leading 
us to concentrate on a group of cuticle collagen genes.  
The cuticle serves as the exoskeleton of the worm and its main component is 
collagen, encoded by more than 170 genes in the cuticular collagen multigene family 100. 
The cuticle is synthesized and secreted by the underlying hypodermis, and polymerizes 
on the external surface forming the exoskeleton. At the end of each larval stage, the 
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cuticle molts revealing a newly formed cuticle underneath. Some cuticle collagen genes 
are expressed in specific larval stages while others are expressed in each cuticle synthesis 
period 69. In spite of extensive study, only a few of the cuticle collagen genes have been 
described to have visible mutant phenotypes; these abnormalities include body 
morphology defects such as DumPY (Dpy), ROLler (Rol), BLIster (Bli), Squat (Sqt), and 
LONg (Lon) 63. We reasoned that altered expression of cuticle collagen genes could 
contribute to the small body size phenotype of DBL-1 pathway mutants.  
We show here that cuticle collagen genes are direct and indirect transcriptional 
targets of the DBL-1 pathway. We demonstrate SMA-4 (co-Smad) binding in the 
intergenic region between col-141 and col-142. This result is the first demonstration that 
the DBL-1 pathway Smads binds DNA in vitro, further validating the functional 
conservation of Smads in the nematode model. We find that other collagen genes are 
likely indirect targets of the DBL-1 pathway. Moreover, we observe loss of stage-specific 
expression of cuticle collagens in the absence of DBL-1 signaling. Lastly, we 
demonstrate through collagen loss-of-function mutants, RNAi, and overexpression 
studies that cuticle collagens are the effectors of body size regulation by the DBL-1 
pathway.  
Results 
II3.1 Cuticle collagen genes are transcriptional targets of the DBL-1 pathway and are 
required for normal body size. 
We sought to connect the DBL-1 transcriptional program to its downstream 
effectors of body size regulation. In previous work, we identified five putative target 
genes with body size phenotypes 70, but all of these genes encode signaling molecules or 
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transcription factors, so they are not the downstream effectors of growth control. It has 
been proposed that changes in hypodermal polyploidy contribute to the reduced growth 
of dbl-1 mutant adults 101, although these changes cannot account for differences in size 
during larval stages. We tested the functions of putative target genes encoding DNA 
licensing factors and cyclins that could regulate polyploidization, but knockdown of these 
genes by RNAi did not produce body size phenotypes (Supplemental Fig. S1). We next 
turned our attention to four cuticle collagen genes that we identified as putative 
transcriptional targets of the DBL-1 pathway. We performed qRT-PCR to verify 
transcriptional changes in cuticle collagen genes. We compared expression in dbl-1 and 
sma-3 mutants to wild-type controls at the second larval (L2) stage, the same stage in 
which the microarray analysis had been conducted. In absence of DBL-1 signaling, rol-6 
and col-41 are down regulated while col-141 and col-142 are up-regulated (Table 1), in 
agreement with the microarray studies.  
We hypothesized that regulated expression of these cuticle collagen genes 
contributes to body size regulation. An alternative hypothesis is that the altered 
expression of cuticle collagen genes is a response to, rather than a cause of, the altered 
size of dbl-1 mutants 102. To address the role of these cuticle collagen genes in body size 
regulation, we performed RNAi of col-41, rol-6, and col-141 and measured body length 
at different time points during larval and adult growth (Fig. 1A). RNAi of col-41 and rol-
6 led to a decrease in body size at all stages. Conversely, col-141 RNAi led to a transient 
increase in body size in the larval stages, suggesting that cuticle collagens can act as 
negative as well as positive regulators of body size. We verified our results using an 
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available loss-of-function mutation in rol-6. This rol-6 (lf) mutant also has a small body 
size, as illustrated by body length measured at the L4 stage (Fig. 1B). 
If cuticle collagen expression is truly instructive rather than permissive for body 
size regulation, we would expect that overexpression of respective collagens should also 
lead to body size changes. Therefore, we performed overexpression of col-141 and col-
142, by increasing copy number in transgenics carrying a genomic fragment that contains 
both genes, which are adjacent in the genome. Overexpression of col-141 and col-142 
resulted in decreased body size relative to wild-type worms (Fig. 1B), confirming these 
genes as negative regulators of growth.  
Table 1. Cuticle collagen genes are transcriptional targets of the DBL-1 pathway 
Gene 













rol-6 -2.15 -1.3 ND 3.6 
col-41 -2.64 -1.2 -1.4 1.6 
col-141 3.19 1.6 1.7 -1.7 
col-142 2.65 ND 1.5 -1.2 
Microarray results are reproduced from 70. qRT-PCR results are from representative 
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Figure 1. Cuticle collagen gene inhibition and overexpression leads to body size phenotypes. A. RNAi 
inhibition of col-41, rol-6, and col-141 led to changes in body size. Animals were measured at indicated 
time points following embryo collection. B. Comparing body size phenotype of rol-6(mt2709) mutant and 
overexpressing col-141col-142 worms relative to wild type. Body length was measured at the L4 stage. An 
independently generated transgenic line gave equivalent results. C. Overexpression of rol-6 leads to smaller 
body size. rol-6 RNAi in the rol-6 overexpression line alleviates small body size. Body length was 
measured at the L4 stage. An independently generated transgenic line gave equivalent results. OE-
overexpression; Control-Empty Vector. Error bars show standard error. * P < 0.05, ** P < 0.005, ***P < 
0.0005. 
 
We performed a similar experiment to overexpress rol-6. Surprisingly, 
overexpression of rol-6 led to a decrease, rather than an increase, in body size (Fig. 1C). 
To confirm that the observed phenotypes were due to rol-6 overexpression, rather than an 
artifact of the transgene, we performed rol-6 RNAi on the overexpression lines to reduce 
the level of overexpression. This RNAi inhibition of rol-6 expression ameliorated the 
decreased body size in the overexpressing lines (Fig. 1C). These results suggest that rol-6 
is dose-sensitive and must be expressed in a particular range; otherwise aberrant body 
size is observed.  
	   	  24	  
 
II.3.2 Cuticle collagen genes are direct and indirect targets of DBL-1 Smads. 
To identify which transcriptional targets of DBL-1 signaling were potentially 
directly regulated by Smad binding, genome-wide ChIP-seq was performed using a strain 
expressing functional GFP::SMA-3 from the endogenous sma-3 promoter, in a sma-
3(wk30) background. Using the Galaxy software 103-105, we extracted genomic sequences 
from the coordinates obtained via ChIP-seq. MEME-ChIP software 106 was used to 
discover enriched motifs and generate logo plots. The top two enriched motifs were the 
CTGCGTCT SBE and GAGA (Fig. 2A). The presence of GTCT as an enriched motif 
indicates an increased presence of SMA-3 at the indicated association sites. Among the 
cuticle collagen genes that we established as transcriptional targets, the intergenic region 
between col-141 and col-142 had strong Smad binding (Fig. 2B). No additional SMA-3 
recruitment sites were identified in this genomic region, suggesting that the intergenic 
region serves to regulate both genes. We therefore chose to study this region, which we 
will refer to hereafter as col-p. In contrast to col-141 and col-142, SMA-3 ChIP-seq peaks 
were not found in the genomic regions surrounding col-41 (Fig. 2B).   
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Figure 2.  SMA-3 associates with Smad Binding Elements in the intergenic region between col-141 
and col-142 (col-p). A. SMA-3 ChIP sequencing revealed SBE as highly enriched motif via MEME-ChIP 
motif discovery analysis. B. SMA-3 associates with the intergenic region between col-141 and col-142 
(col-p). C. No peaks of SMA-3 are detected in the genomic region surrounding col-41. 
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II3.3 Smads associate with Smad Binding Elements in col-p. 
We generated a multiple sequence alignment between col-p sequences from three 
related nematode species (Fig. 3A). This analysis of col-p revealed multiple SBEs, some 
of which are conserved between two or three analyzed species. To elucidate the 
molecular requirements for Smad recruitment, we used the electrophoretic mobility shift 
assay (EMSA) to test R-Smad SMA-3 and co-Smad SMA-4 binding to putative 
regulatory sequences. The MH1 Smad DNA-binding domains were expressed as GST 
fusion proteins in bacteria. We used an artificial Smad-binding sequence based on the 
well-characterized RAD-SMAD reporter 28 as a positive control. SMA-4 MH1 domain 
binds strongly to this probe (Fig. 4A). We then generated four probes from col-p based 
on sequence alignment and the presence of GTCT sequences (Fig. 4C). SMA-4 MH1 
domain strongly and specifically bound to probes 3 and 4 (Fig. 4A-B). To determine if 
the conserved SBEs are necessary for SMA-4 binding, we introduced two single base pair 
substitutions in the SBEs, changing GTCT to ATCT. Unlabeled wild-type and mutant 
probes were used in a competition assay with labeled wild-type probe 3. Unlike wild-type 
probes, mutant probes with ATCT are unable to compete for SMA-4 binding (Fig. 4B). 
Therefore, SMA-4 binding depends on intact GTCT sequences. Overall, our EMSA 
results indicate that SMA-4 can bind at least two specific sites in col-p (in probes 3 and 
4). Both probes 3 and 4 contain two GTCT sites, its plausible that having multiple sites in 
tandem or in proximity, makes that sequence a more likely target for binding. Additional 
binding sites may also be present, because we did not test the entire intergenic region. 
SMA-3 MH1 domain did not bind to any of the tested probes, possibly because BMP R-
Smads prefers GC-SBEs to canonical SBEs (see Discussion). 
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Figure 3. Multiple conserved SBEs are present in the intergenic region between col-141 and col-142.  
A. Five out of the six putative SBE sites are conserved among multiple Caenorhabditis species in the 
intergenic region between col-141 and col-142. Nucleotide alignments were made using ClustalW. B. 
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II.3.4 Identification of genomic sequences required for col-141 and col-142 expression.  
Having identified Smad binding sites in col-p, we further aimed to determine 
whether these sites are relevant for gene expression in vivo. Hence, we created a construct 
with col-p driving expression of 2x nuclear localized (NLS) mCherry and obtained 
multiple lines via microinjection. mCherry expression was observed in the hypodermis 
and in the vulva at the adult stage (Fig. 5A-C), confirming the ability of col-p to drive 
gene expression. Expression was specific to the adult stage only, in alignment with 
Jackson et al. 69 which showed peak col-141 and col-142 expression at the adult stage. To 
test if the DBL-1 pathway would regulate mCherry expression, we further crossed these 
lines into sma-3 mutant background. We observed little to no expression of mCherry 
expression at all stages (Fig. 5D-F). We quantitated fluorescence intensity and found that 
it was significantly reduced (Fig. 5G). This result did not align with our microarray and 
qRT-PCR results, which showed increased rather than decreased expression of col-141 
and col-142 in DBL-1 pathway mutants. However, those assays were conducted at the L2 
stage, at which time fluorescence of our reporter is undetectable. As described below, 
qRT-PCR experiments in adult animals are consistent with our reporter results.  
To test if SBEs present in col-p are relevant for mCherry expression, we made 
transgenic animals with mutated SBEs (mt.col-p) driving 2xNLS::mCherry. We noted 
complete loss of mCherry expression except in the vulva (Fig. 5J), indicating Smad 
binding at these SBEs is required for gene expression in the hypodermis (Fig. 5H-I). To 
test if mCherry expression was the same in the presence and absence of sma-3, we 
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crossed these worms into sma-3 mutant background (Fig. 5K-M). Again, we observed a 




Figure 4. Smads bind directly to SBEs in col-p. A. SMA-4 strongly binds to probe 3 and probe 4 
containing SBEs. B. SMA-4 binds specifically to SBE (2xGTCT) in Probe 3. C. Probes from col-p region 
used to test binding of Smad MH1 DNA binding domains. SBEs are capitalized in red. 
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To verify the results from our extrachromosomal reporter, we wanted to study the 
expression of col-141 in its endogenous genomic environment. Utilizing CRISPR-Cas9, 
we knocked in 2xNLS::GFP to replace col-141 making a transcriptional reporter and a 
loss of function simultaneously (Fig. 6A). We characterized the reporter and observed 
that GFP expression is only visible at the adult stage in the hypodermis alone (Fig. 6B-
D), with little to no expression observed in larval stages, consistent with the result from 
the extrachromosomal reporter. To confirm whether DBL-1 signaling transcriptionally 
regulates GFP expression, we crossed the col-141 reporter into a sma-3 mutant 
background (Fig. 6E-G). We observed a loss of GFP expression, replicating the results of 
the extrachromosomal col-p::2xNLSmCherry transgenic animals (Fig. 5A,D).  
This genome-edited animal also allowed us to determine the body size phenotype 
of col-141(lf) and compare it to col-141(RNAi). We measured body length of col-141(lf) 
at L2, L4, and adult stages and found that it is longer than controls at all three stages (Fig. 
5H, Supplemental Fig. S2). This was analogous to the RNAi results (Fig. 1A), except that 
body length differences persisted into adulthood in the mutants. Since col-141 shares 
sequence homology with col-142, we wondered if there could be partial functional 
redundancy between the two genes. We therefore performed RNAi targeting col-142 on 
the col-141 (lf) mutant and observed a further increase in body size in adults compared to 
col-141 (lf) alone, and compared to wild type (Fig. 5H). Therefore, col-142 is partially 
redundant with col-141 in adults. 
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Figure 5. Identification of genomic sequences required for col-141 expression. A-C. 
col-p::2xNLS::mCherry leads to adult stage specific expression in the hypodermis nuclei. D-F. mCherry 
expression is severely depleted in sma-3 mutant background. G. Quantification of mCherry expression in 
wild type and sma-3 mutant background. Error bars show standard error. * P < 0.05, ** P < 0.005, *** P < 
0.0005 H-J. Mutating SBE 3 from GTCT to ATCA, SBE 4 from AGAC to TGAT leads to loss of mCherry 
expression. K-M. Crossing of mt.col-p::2xNLS::mCherry into sma-3 mutant background does not change 
the ablated mCherry expression. A,D,H,K fluorescent images; B,E,I,L Nomarski images; C,F merged 
images; J,M merged images showing expression in the vulval region. 
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II.3.5 DBL-1 signaling is required for stage-specific regulation of cuticle collagen genes. 
 
We sought to resolve our discrepant results on the direction of regulation of col-
141 and col-142 by the DBL-1 pathway. Initial qRT-PCR performed at the L2 stage 
indicated an increase in col-141 and col-142 expression in DBL-1 pathway mutants 
(Table 1). Meanwhile, the col-p::2xNLSmCherry and col-141(lf[2xNLS::gfp]) strains 
showed a reduction of expression at the adult stage.  To confirm that loss of fluorescence 
expression in col-141(lf[2xNLS::gfp]) and col-p::2xNLSmCherry replicated col-141 and 
col-142 expression in sma-3 mutant background, we performed qRT-PCR on sma-3 
mutant adults. We observed a significant decrease in col-141 and col-142 levels in sma-3 
mutant adults (Table 1), corroborating the observations from our transcriptional reporters. 
Therefore, the direction of action of the DBL-1 pathway on col-141 and col-142 
expression is stage-specific. We extended these observations by determining the 
expression levels of col-41 and rol-6 in sma-3 mutant adults. In these experiments, we 
observed an increase in col-41 and rol-6 levels (Table 1), again reversing the direct of 
regulation in comparison with the L2 stage. These results suggest that DBL-1 signaling is 
required for the appropriate temporal stage-specific expression of cuticle collagen genes.  
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Figure 6. An endogenous CRISPR-generated reporter verifies requirements for col-141 expression. 
A. Utilizing CRISPR-Cas9 genome editing to knock out and replace col-141 with 2xNLS::gfp, creating a 
loss of function mutant and transcriptional reporter simultaneously. B-D. GFP expression in col-141(lf) 
mutant. E-G. Loss of GFP expression in sma-3 mutant background. B,E fluorescent images; C,F Nomarski 
images; D,G merged images. H. Body size phenotypes of col-141(lf), col-142(RNAi) and doubles. Error 
bars show standard error. * P < 0.05, ** P < 0.005, *** P < 0.0005. 
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II.4 Discussion 
 
Body size regulation has been investigated in multiple organisms, including 
humans 107,108 mice, dogs, and Drosophila 57,109-111. In these organisms, signaling 
pathways have been identified that contribute to body size regulation; however, the 
effector genes for body size regulation through those pathways are poorly characterized. 
We have capitalized on the genetic tractability of C. elegans to study how the conserved 
DBL-1 BMP-related signaling pathway regulates body size. In our work, we elucidated 
the transcriptional network initiated by DBL-1 to explain how body size is modulated by 
DBL-1 activity. We have shown that cuticle collagen genes are transcriptional targets of 
the DBL-1 pathway via microarray analysis and qRT-PCR. Moreover, we showed that 
DBL-1 is required for stage-specific expression of cuticle collagen genes. Through 
RNAi, mutant, and overexpression studies we discovered a positive regulator (col-41), a 
dose-sensitive regulator (rol-6) and negative regulators (col-141, col-142) of body size. 
We showed association of Smads in the intergenic region between col-141 and col-142 
via ChIP-seq and using EMSA we showed in vitro binding of SMA-4 MH1 domain to 
conserved SBE sites in this region. Additionally, we show lack of binding by Smads to 
the previously defined col-41 promoter region. Hence, cuticle collagen genes are directly 
and indirectly regulated via the DBL-1 pathway. Based on presented evidence, we 
conclude that cuticle collagen genes are major effectors of body size through the DBL-1 
pathway. We speculate that the specific collagen isoforms deposited in the cuticle 
contribute to the characteristics of that cuticle, due to differences in how they crosslink 
with other components. COL-41, as a positive regulator of growth, may contribute to a 
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more elastic, expandable cuticle. COL-141 and COL-142, as negative regulators of 
growth, may contribute to a more rigid, less easily expanded cuticle. 
Since cuticle collagen genes are encoded by such a large gene family in C. 
elegans, it is reasonable to ask why so many genes are required. One possible explanation 
is that the large number of genes allows rapid synthesis of the cuticle during the discrete 
cuticle synthesis periods of the worm’s lifecycle. Our work supports the notion that there 
is also a degree of functional specificity. Consistent with this hypothesis, more than 60% 
of cuticle collagen genes have been described as having stage-specific expression 
patterns 69. In particular, col-41 and rol-6 have peaks of expression in the L2 stage, while 
col-141 and col-142 have highest expression in adults. In addition to our own work, two 
published microarray analyses identified cuticle collagen genes as transcriptional targets 
of the DBL-1 pathway 70,102,112. Furthermore, specific subsets of cuticle collagen genes 
have been described as transcriptional targets of Wnt and insulin signaling pathways in C. 
elegans 68,69. Both DBL-1 and Wnt pathway mutants have been shown to have cuticle 
defects 69,113, demonstrating that there are functional consequences to the alterations in 
collagen gene expression. Furthermore, Ewald et al. 68 demonstrated that specific cuticle 
collagens (which include col-141) contribute to the regulation of longevity by the insulin 
signaling pathway. 
In humans, collagens constitute ~30% of the protein mass and are the most 
abundant protein. Collagens function in a diverse range of processes such as mechanical 
properties of tissue, ligands for receptors, cell growth, differentiation, cell migration, 
bone formation, skeletogenesis, and the integrity and function of the epidermis 71-73. The 
expression levels of collagens must be tightly controlled during wound healing, and 
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inappropriate expression of collagens can lead to fibrosis 114,115. Mutations in collagens 
have been recognized in rare heritable diseases such as osteogenesis imperfecta, several 
subtypes of Ehlers-Danlos syndrome, various chondrodysplasias, X-linked forms of 
Alpoty syndrome, Ullrich muscular dystrophy, corneal endothelial dystrophy, and 
Knobloch syndrome 76. Collagen mutations as seen in osteogenesis imperfecta can result 
in increased TGF-β signaling 116. Therefore, collagens and their regulation have 
significant implications for human health. Our work further adds to the functional 
importance of collagens in the context of growth regulation.  
In addition to highlighting the functional significance of collagen genes, our work 
sheds light on the mechanisms of action of the DBL-1 Smads. Three Smads act in this 
pathway: the R-Smads SMA-2 and SMA-3 and the co-Smad SMA-4. All three Smads are 
necessary for pathway function, and they presumably form a heterotrimeric complex. We 
performed genome-wide ChIP-seq analysis on GFP::SMA-3 and identified GTCT, the 
canonical SBE, as enriched at sites of SMA-3 occupancy. In Drosophila, Mad, the Dpp 
R-Smad, binds GC-rich Smad binding sites termed GC-SBE (GGAGCC) 117, while 
Medea, the Dpp co-Smad, binds canonical SBEs (GTCT).  In our analyses of targets of 
the DBL-1 pathway, we observed Smad binding to the intergenic region between col-141 
and col-142. We therefore tested for direct binding of isolated MH1 domains of Smads 
SMA-3 and SMA-4 to SBEs in this region. Consistent with findings in Drosophila, the 
MH1 domain of co-Smad SMA-4, but not that of R-Smad SMA-3, was able to bind the 
SBE’s directly in vitro. Similarly, the co-Smad of the C. elegans DAF-7/TGF-β pathway, 
DAF-3, has previously been shown to bind canonical GTCT sequences 118. Since there is 
no evidence for direct binding of R-Smad SMA-3 to GTCT sequences, the enrichment of 
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this motif at SMA-3 genomic binding sites may be due to SMA-3 being recruited as part 
of the Smad complex, with co-Smad SMA-4 making the direct contact with this site.  
In conclusion, our work elucidates the transcriptional network for body size 
regulation through the DBL-1/BMP pathway in C. elegans. We propose a model (Fig. 7) 
in which DBL-1 signaling leads to Smad activation causing direct and indirect regulation 
of specific cuticle collagen genes. This regulation occurs in a stage-specific manner to 
initiate the correct temporal program of collagen gene expression. Inappropriate 
expression of cuticle collagen genes leads to aberrant body size.  This work thus provides 
the first mechanistic link between BMP signaling and effectors of body size regulation. 
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Figure 7. DBL-1 regulation of growth. Our model proposes stage-specific regulation of cuticle collagen 
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Figure S1. Body size following RNAi of DBL-1 transcriptional targets that encode potential 
endoreduplication regulators. Body length was measured at 96 hours after embryo collection. Error bars 




Figure S2. Body size of col-141(lf) CRISPR strain. Body size was measured at L2, L4 and adult stages. 
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II.5 Materials and Methods 
RNA interference (RNAi) 
RNAi by feeding was performed as described 119,120. RNAi clones that target the unique 
(non-Gly-X-Y repeat) regions of collagen genes were generated by cloning desired PCR 
fragments into L4440.  
 
Electrophoretic Mobility Shift Assay (EMSA) 
Protein purification: GST tagged versions of the MH1 domains of SMA-2, SMA-3, and 
SMA-4 were cloned in the pGEX-4T2 vector. All three proteins were isolated using 
BL21 competent cells, grown in a starter culture O/N at 37°!. From the starter culture a 
fresh culture of 100 ml was started, grown at 37°! until O.D. of 500 was reached. 
Expression was induced using IPTG at final concentration of 1 mM in 100 ml cultures 
and grown at 28°C for 6-8 hours. Standard batch purification was performed using GST 
beads and eluted in 30 mM reduced glutathione and 50 mM Tris buffer, pH 8.0. Three 
elutions were taken, each of the primary elutions were run on 4-12% Bis-Tris gels (Life 
Technology) for size separation under denaturing conditions. EMSA Gel Shifts: Double 
stranded probes were labeled with 32P and incubated with protein in binding buffer at RT 
for 20 minutes. Binding Buffer was composed of 50% glycerol, 100mM HEPES, 15mM 
DTT, 0.5mg/ml BSA, 0.5M KCl, 50mM ZnSO4, 50 µg/ml dIdC, samples were run on 5% 
native acrylamide gel for 1-1.5 hours, dried for one hour at 65°C  and developed for 1 
hour at -80 °C . Probe 1: ttcaaaataagacaacacagaaagtagggt. Probe 2: 
tgaccttttcatgatcataagacccggttt. Probe 3: acggtttcaaggtctgtctcctcgaacacg. Probe 4: 
ggtgagacaagcaatgagaatagacacaca.  




Worms were grown at 20°C  until a large amount of eggs were observed on plates. 
Worms were then washed off using M9 buffer and the remaining eggs were allowed to 
hatch for 4 hours. Worms were then collected and placed on new plates and grown at 
20°C until late L2 or adult stage, collected and mRNA was extracted using the RNeasy 
mini kit (Qiagen). Reverse transcriptase PCR and quantitative real time PCR were 
performed as previously described 121.  
 
ChIP-Seq 
ChIP-seq was performed by Michelle Kudron (Valerie Reinke modENCODE/modERN 
group) on sma-3(wk30);Is[GFP::SMA-3] strain at late L2 stage 122. 
 
Genome editing and transgenic strains  
To obtain a col-141 knock-in line via CRISPR-Cas9 we followed the Dickinson 123 
protocol and used the selection excision cassette pDD282 vector. All constructs were 
assembled using NEB Hi-fi DNA Assembly kit. All other strains were constructed by 
microinjections, myo-2::gfp (20 ng/ml), transgene of interest (100 ng/ml), carrier DNA 
(80 ng/ml). col-141 and col-142 overexpression lines were created via microinjection (50 
ng/ml each, myo-2::gfp at 12 ng/ml). rol-6 overexpression lines were made via injection 
of rol-6 (50 ng/ml) and myo-2::gfp (10 ng/ml). 
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Note: For this published work (Yin et al. 2015) I performed RNAi of elt-1 and elt-3 
followed by quantification of transcript levels of col-41, dpy-7, elt-1, and elt-3 via QRT-
PCR. 
Abstract 
The cuticle of the nematode Caenorhabditis elegans is a specialized extracellular matrix 
whose major component is collagen. Cuticle collagens are encoded by a large multi-gene 
family consisting of more than 150 members. Cuticle collagen genes are expressed in 
epidermis (hypodermis) and may be stage-specific or cyclically expressed. We identified 
cuticle collagen genes as transcriptional targets of the DBL-1 TGF-β-related signaling 
pathway. These studies prompted us to investigate the cis-regulatory sequences required 
for transcription of one of the target genes, col-41. We generated reporter constructs that 
reproduce stage- and tissue-specific expression of fluorescent markers. We identify four 
conserved sequence elements that are required for transcription of reporters. Finally, we 
provide evidence that col-41 expression is controlled by a sequence element containing 
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Introduction 
In the nematode C. elegans, the cuticle serves as an exoskeleton required for proper 
growth and defense of the animal 124. Collagen is the major component of the cuticle and 
is encoded by a large multi-gene family. Cuticle collagen genes are expressed in the 
epidermis (hypodermis), a large multinucleate tissue that surrounds the nematode body. 
Collagen is secreted from the apical surface of the epidermal cells to the exterior of the 
body. Cuticle collagen genes show highly specific temporal expression patterns that may 
be stage-specific or cycle in phase with the cuticle molts 93,125,126. Additionally, levels and 
timing of cuticle collagen gene expression respond to cell signaling pathways, such as the 
TGFβ and Wnt pathways 102,125,127. 
 
In our studies of the transcriptional response to the TGFβ family member DBL-1, we 
identified col-41 and other cuticle collagen genes as transcriptional targets whose 
expression levels depend on the activity of the signaling pathway 127. This finding 
prompted us to investigate the cis-regulatory requirements for accurate transcription of 
the col-41 gene. Although expression studies of cuticle collagen genes have been 
previously performed, little is known about the sequence elements that contribute to 
collagen gene regulation. In this study, we use transcriptional reporters to characterize 
col-41 regulatory sequences. We identify a 0.5kb promoter region that directs stage- and 
tissue-specific regulation of a fluorescent marker and additional upstream sequences that 
contribute to robust, reproducible expression. Within these regions, we identify four 
conserved sequence motifs that are required for optimal activation of the reporter, two of 
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which are essential for any detectable expression. One of the essential elements contains 
two GATA motifs. We provide evidence that col-41 may be regulated by the epidermal-
specific GATA factors ELT-1 and ELT-3. 
 
Results and Discussion 
Cuticle collagen genes were identified via microarray analysis as transcriptional targets 
of the DBL-1 signaling pathway 127. DBL-1 regulates multiple developmental and 
homeostatic functions in C. elegans, one of which is body size 128,129. Since cuticle 
collagen genes are known to regulate body size and morphology, we were interested in 
these target genes as potential mediators of DBL-1 regulation of body size. Furthermore, 
recent evidence suggests that defects in the cuticle underlie multiple abnormalities seen in 
DBL-1 pathway mutants 113. To investigate collagen gene expression in vivo, we 
generated transcriptional GFP reporters using upstream genomic sequences for the target 
genes col-37, col-41 and col-141. GFP expression was undetectable for col-37 and col-
141 (data not shown), suggesting either that our constructs were missing critical 
regulatory sequences, or that expression levels were below our level of detection.  
 
In contrast, transcriptional fusions for col-41 containing 1.6kb of upstream sequences 
fused to GFP or to nuclear localized 2xNLS-mCherry showed detectable expression. We 
chose 1.6kb since this was the distance to the nearest upstream transcript in the genome 
annotation at the time. (Current annotations show the presence of three small exons in 
this region from a gene transcribed in the opposite orientation). Reporter constructs were 
microinjected into the C. elegans gonad to create transgenic lines followed by transgene 
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integration using γ-irradiation. Integrated col-41p::2xNLS::mCherry transgenes are 
expressed in a tissue-specific and stage-specific manner. mCherry expression is observed 
in epidermal nuclei in L3 and early L4 larval stage animals (Fig. 1a). mCherry is also 
expressed in the vulval precursor cells, a ventral epidermal lineage, during the L3 stage 
(Fig. 1b). Expression is absent from the lateral epidermal seam cells; this absence is more 
apparent in the GFP reporter, which is not nuclear localized and therefore shows diffuse 
fluorescence throughout the cytoplasm (Fig. 1c). The spatial expression pattern is very 
similar to that reported for the cuticle collagen gene dpy-7 130. Temporally, however, 
COL-41 appears to be a larval-specific cuticle collagen, with expression absent from 
embryos and adults. This result is consistent with RNAseq analyses that demonstrate a 
peak of col-41 expression in L2 125,131. Expression of the fluorescent marker may be 
visible later than the peak in mRNA expression due to the time lag for protein synthesis 
and maturation, and/or perdurance of the mCherry protein. The observed expression 
timing is consistent with col-41 being identified as a target of the DBL-1 pathway at the 
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Fig. 1. col-41 transcriptional reporters’ direct expression in the epidermis. (a) 
Expression of 1.6kb col-41p::2xNLS::mCherry reporter in epidermal nuclei during L3 
stage. (b) Expression of 1.6kb col-41p::2xNLS::mCherry  reporter in vulval precursor 
cells (marked by arrows) during L3 stage. (c) Expression of 1.6kb col-41p::GFP reporter 
in the epidermis is excluded from the lateral epidermal seam cells. (d) The 0.5kb col-




Next, we analyzed the putative regulatory sequences of col-41 in more detail. We aligned 
col-41 upstream sequences from three closely related nematodes, C. briggsae, C. remanei 
and C. elegans. Sequence conservation was most prominent in the proximal 0.5kb (Fig. 
2). We therefore created separate mCherry reporter constructs containing the proximal 
0.5kb and distal 1.1kb col-41 promoter fragments to generate transgenic animals as 
described above. In vivo, the reporter construct with the distal 1.1kb promoter fragment is 
not sufficient for expression (data not shown). In contrast, mCherry expression driven by 
the proximal 0.5kb promoter fragment results in tissue-specific (epidermal) and stage-
specific (early larval) expression (Fig. 1d).  However, expression appeared to be less 
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robust from the 0.5kb construct, since in multiple integrated lines only ~60% of 
transgenic animals showed expression (four integrated lines were analyzed). We 
conclude that sequences in the proximal 1.1kb region contribute to reproducible 
expression of col-41. There is precedent for such mechanisms for producing robust and 
reproducible expression via redundant cis-acting elements and “shadow” enhancers 132. 
 
From the sequence alignment, we identified 6 conserved sequence elements (Fig. 2). We 
deleted the three proximal elements in the context of the 0.5kb promoter fragment and the 
three distal elements in the context of the 1.6kb promoter (Fig. 3). Deletion constructs 
were microinjected into nematodes, transgenes were integrated, and expression was 
analyzed by fluorescence microscopy. Images in Fig. 4 were taken on the same day with 
the same exposure times. Deletions 1 and 2 show no detectable mCherry expression (data 
not shown). Deletions 3 and 6 have reduced levels of mCherry expression (Fig. 4b, e). 
Deletions 4 and 5 show levels of expression similar to the wild-type 1.6kb construct (Fig. 
4a, c, d). None of these deletions produced any ectopic expression, either temporally or 
spatially. Taken together, we conclude that elements 1, 2, 3, and 6, but not elements 4 and 
5, are required for col-41 expression. Additionally, since deletion 6 in the context of the 
full 1.6kb promoter has a lower level of expression than the 0.5kb promoter (that lacks 
element 6), we conclude that the 1.1kb region also contains an undefined repressor 
element. 
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Fig. 2. Alignment of upstream sequences of col-41 orthologs from C. elegans, C. 
briggsae, and C. remanei. Alignment was performed using Clustalw. * indicates 
identical nucleotides. Red boxes indicate conserved regions that were deleted in reporter 
constructs. 
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Fig. 3. col-41 promoter constructs. Yellow bars indicate conserved regions. Deletions 
are indicated by the delta (inverted triangle) symbol. 
 
We examined sequence elements 1, 2, 3, and 6 for potential transcription factor binding 
sites (Fig. 2). Since we identified col-41 as a transcriptional target of DBL-1, a TGFβ-
related ligand 133, we first searched for sequences related to TGFβ signaling. TGFβ 
responses are mediated by Smad transcription factors, which bind two types of 
sequences: GTCT Smad Binding Elements (SBEs) or GRCGNC GC-rich sequences 134-
136. Element 6 contains one potential GTCT Smad Binding Element (SBE). Most Smad 
target genes, however, contain more than one SBE, and the GTCT upstream of col-41 is 
not conserved in C. remanei (Fig. 2). Thus, at this time, we do not have evidence to 
distinguish between col-41 as a direct or indirect target of Smads. 
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 Fig. 4. Expression of col-41 deletion series reporters. (a) 1.6kb promoter control; (b) 
Deletion 3 has no detectable expression; (c) Deletion 4 has normal levels of expression; 
(d) Deletion 5 has normal levels of expression; (e) Deletion 6 has reduced levels of 
expression. 
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Element 2 contains two potential GATA sites. The GATA motif is a common binding 
site for transcription factors, including GATA factors. In C. elegans, specific GATA 
factor genes act as master regulators of intestinal and epidermal fates: elt-2 and elt-7 in 
the intestine 137 and elt-1 and elt-3 in the epidermis 138. We therefore tested whether 
GATA factors play a role in the transcriptional regulation of col-41. We used RNAi by 
feeding to inactivate the GATA factor genes elt-1, elt-2, and elt-3 in animals carrying the 
1.6k col-41 reporter construct. We found that inhibition of the intestinal GATA factor 
gene elt-2 had no effect on expression, as expected (Fig. 5b). On the other hand, 
inhibition of the epidermal GATA factor gene elt-1 caused a reduction in mCherry 
expression (Fig. 5a). Somewhat surprisingly, inhibition of elt-3, another epidermal 
GATA factor gene, resulted in increased mCherry expression (Fig. 5c). We therefore 
conclude that ELT-1 plays a role in transcriptional activation of col-41 in the epidermis. 
ELT-3, on the other hand, may be a transcriptional repressor of col-41 or have a more 
complex regulatory interaction with col-41. Interestingly, the GATA factor GATA-4 has 
been identified as a transcriptional repressor for human COL1A2  139, which could 
indicate a conserved regulatory mechanism for invertebrate and vertebrate collagens.  
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Fig. 5. Depletion of epidermal, but not intestinal, GATA factors results in altered 
expression of cuticle collagen genes. (a-c) Expression of col-41 transcriptional reporter. 
The respective empty vector control for each experiment is shown to the left. (a) elt-1 
RNAi (epidermal); (b) elt-2 RNAi (intestinal); (c) elt-3 RNAi (epidermal). (d) 
Quantitative RT-PCR analysis of col-41, dpy-7, elt-1 and elt-3 upon elt-1 and elt-3 RNAi. 
col-41 expression is dependent on ELT-1 and, to a lesser extent, ELT-3. dpy-7 expression 
is dependent on ELT-3. Data are averages of trials from three biologically independent 
replicates; error bars show standard deviation. Transcript levels are determined in L2 
stage; note that elt-1 transcript levels and functional activity are higher during 
embryogenesis. 
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To clarify these regulatory interactions, we used qRT-PCR to determine transcript levels 
of the endogenous col-41 gene upon RNAi of elt-1 and elt-3. elt-1 is required in embryos 
to specify epidermal fates and is a transcriptional activator of elt-3 140,141. Null mutations 
in elt-1 are lethal, but partial loss of function by RNAi is viable. As expected, elt-1(RNAi) 
caused reduced transcript levels for both elt-1 and elt-3 (Fig. 5d). Additionally, consistent 
with the transgenic reporter results, we found that col-41 transcript levels are reduced in 
elt-1(RNAi) animals (Fig. 5d). elt-3 is required for maintenance of epidermal fates and 
null alleles are viable 140. Due to the lack of lethality, elt-3(RNAi) efficiently reduced elt-3 
transcript levels (Fig. 5d). It also reduced elt-1 transcript levels, suggesting that ELT-3 is 
required for maintenance of elt-1 expression, which has not previously been reported. 
Unexpectedly, we saw a slight reduction in col-41 transcript levels in elt-3(RNAi) animals 
(Fig. 5d), as opposed to the increase seen in the transgenic reporter. This result suggests 
that our transgenic reporter may be missing sequences required for the correct direction 
of the regulatory interaction. Consistent with the hypothesis of direct regulation of col-41 
by ELT-3 is the identification of ELT-3 binding upstream of col-41 by ChIP-seq analysis 
142. 
 
We were interested to determine whether regulation of cuticle collagen genes by GATA 
factors is a general phenomenon. Expression analyses of dpy-7 collagen have identified a 
GATA sequence in the minimal promoter region 130. We therefore determined dpy-7 
transcript levels in elt-1 and elt-3 knockdowns. We find that ELT-3, but not ELT-1, is 
required for normal expression of dpy-7 (Fig. 5d). Furthermore, like col-41, the dpy-7 
locus is associated with direct binding of ELT-3 by ChIP-seq 142. 
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In conclusion, we have generated transcriptional reporters for col-41 that can be used to 
mark larval epidermal and vulval precursor nuclei in C. elegans. We have identified four 
conserved elements that are required for expression of col-41. One of these elements 
contains two GATA sites. In vertebrates, GATA factors play critical roles in specification 
of hematopoietic and endoderm lineages 143,144. Similarly, in C. elegans GATA factors 
can specify intestinal and epidermal fates 137,138. In our experiments, depletion of the 
epidermal-specific GATA factor ELT-1 reduced expression of col-41, suggesting that the 
cuticle collagen gene is a direct target of a tissue-specific master regulator. Furthermore, 
expression of the cuticle collagen gene dpy-7 is dependent on the GATA factor ELT-3, 
suggesting that this may be a widespread mechanism for the tissue-specific regulation of 
this multi-gene family. 
  
Methods 
Molecular cloning and sequencing 
The col-41 transcriptional GFP reporter was generated by fusion PCR 145 using 1.6kb 
upstream promoter region and GFP coding region from pPD117.01 as the template. The 
col-41 2xNLS::mCherry transcriptional reporter was generated by PCR cloning of col-41 
upstream sequences into 2xNLS-mCherry (optimized) vector (converted from 
pPD95.75). The col-41 deletion series constructs were generated by using Phusion Site-
Directed Mutagenesis Kit (NEB) and confirmed by sequencing.  
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Transgenic animals 
Transgenic nematodes were generated by microinjection of plasmid DNA (10 ng/µl) with 
myo-2::GFP (5 ng/µl) as a marker 146. Arrays were integrated into chromosomes using γ-




Total RNA was isolated by Trizol (GibcoBRL) and using the Qiagen RNeasy Mini kit 
from N2 (wild-type) worms treated with L4440 (empty vector control), elt-1(RNAi) and 
elt-3(RNAi). Reverse transcription was done using enzyme from SUPERSCRIPT™ III 
Two-Step qRT–PCR (Invitrogen). Real-time PCR was performed using PWR SYBR 
Green PCR Master Mix on Applied Biosystem StepOne 48-well machine 
(Lifetechnologies). Data Analysis software used was StepOne Software version2.2.2. 
Gene act-1 was used as endogenous control. The intron primer of act-1 gene was used to 
test for the presence of genomic DNA. N2 animals were synchronized to late L2 stage 
with a 4-hour synchronization. Three biologically independent samples were collected. 
Each sample was analyzed in two technical replicates. A total of 4 genes (col-41, dpy-7, 
elt-1, and elt-3) was examined in L4440, elt-1, and elt-3 RNAi backgrounds. Results are 
shown as relative quantitation compared with L4440 control. 
 
RNAi 
RNAi feeding was performed as described in 147,148. For transgene reporter experiments, 
12 L4 animals were transferred to feeding plates, incubated overnight, transferred to fresh 
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RNAi feeding plates to lay eggs for 4 hours and the stage-synchronized progeny were 
scored. For qRT-PCR, 50 L4 animals were transferred to RNAi plates and allowed to lay 
eggs overnight. Adults were washed off the plates, leaving unhatched embryos. After 4 
hours, newly hatched L1 animals were transferred to new RNAi plates and allowed to 
develop until late L2 stage. 
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Abstract 
Collagens are a biological molecule with diverse functions ranging from structural 
components of the extracellular matrix (ECM) of connective tissue, to ligands, regulators 
of gene expression and regulators of bioavailability of growth factors. Mutations in 
collagens result in several rare-heritable diseases such as Osteogenesis Imperfecta, Ehler-
Danlos syndrome, Alport syndrome etc. Collagens regulate bioavailability of BMPs by 
directly binding ligands and creating a morphogen gradient as seen in Drosophila or by 
interacting with integrins to enhance BMP signaling. Previously, we established in C. 
elegans that cuticle collagens are effectors of body size regulation via the DBL-1/BMP 
pathway. We questioned whether changes in cuticle structure led to changes in DBL-1 
signaling. To investigate this question, we used reporters of DBL-1 signaling activity, 
transcriptional and translation reporters. We discovered that loss of collagen gene 
function by mutation or RNAi influences DBL-1 signaling at the transcriptional level. A 
dbl-1 transcriptional reporter in a rol-6 null background showed complete ablation of 
reporter expression. The RAD-SMAD reporter, known to respond to changes in DBL-1 
signaling, showed down regulation in activity under RNAi of cuticle collagens.  Further 
work is required to understand the mechanism of changes in DBL-1 transcription due to 




The TGF-β superfamily of ligands is involved in embryonic development and 
imperative cellular processes. TGF-β signaling is highly conserved; the ligand binds to 
type I and type II receptors leading to activation and nuclear translocation of the signal 
transducer transcription factors, which regulate target genes of the pathway149. TGF-β 
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signaling is regulated in multiple ways, ranging from downstream requirements of signal 
transducers to upstream extracellular regulation. Here I focus on extracellular regulation. 
Following secretion of TGF-β, it is bound by latency-associated peptide (LAP, a dimeric 
propeptide) and a latent TGF-β binding protein (LTBP). TGF-β, LAP, and LTBP form a 
complex called the large latent complex (LLC). LTBPs can serve a chaperone function 
for pro-TGF-β by increasing its secretion and folding, correlating with increased TGF-β 
secretion in presence of LTBP150-152. LAP binding to TGF-β makes it inactive and LTBP 
works to direct and sequester TGF-β into the ECM and helps convert TGF-β into its 
active form. The ECM, specifically fibrillin-rich microfibrils, regulates TGF-β by 
controlling diffusion, storage, presentation and release149. LTBPs are directly bound by 
fibrilllin-1 and fibrillin-2. Storage of latent TGF-β by the ECM is considered a 
mechanism to regulate availability as necessary. Activation of latent TGF-β occurs in 
various manners such as via integrins, proteases and changes in pH.  
 Integrins are cell surface adhesion receptors capable of transmitting force across 
the cell membrane between the actin cytoskeleton and extracellular ligands. Integrins 
αvβ6 and αvβ8 are well known to associate with LAP and activate TGF-β153,154. Two 
mechanisms for activation by integrins have been proposed: 1) LAP is bound by integrins 
which are bound to cell’s actin cytoskeleton and LTBPs are bound by fibrillins in the 
ECM. Traction between the ECM and cells is relayed to LAP via LTBP, leading to 
disassociation of LAP from TGF-β, resulting in release of the cytokine152,153,155,156. 2) 
LAP is bound by integrins on the cell surface, making LAP prone to cleavage by 
proteases such as membrane-type metalloproteinase 1 (MT1-MMP), cleavage of LAP 
leads to release of TGF-β from the LLC157. 
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Bone Morphogenetic Proteins (BMPs) are also members of the TGF-β 
superfamily known to be synthesized as complexes with pro-domains and stored in the 
ECM158. However, the bioavailability of BMPs differs from TGF-β. First, BMPs can be 
directly targeted to microfibrils through interactions with their pro-domains and the N-
terminal regions of fibrillin-1 and fibrillin-2159. Second, competitive displacement of the 
pro-domain by type II receptors can activate BMP160, hence activity of free BMP 
complexes can be regulated by antagonists and their modulators alone without an explicit 
requirement for integrin or protease related activation. 
Additional extracellular BMP regulation has been investigated in Drosophila with 
Dpp, a homolog of BMP4. Dpp binds type IV collagen and in absence of this binding 
phenotypes resembling BMP mutants are seen. Type IV collagen is necessary for 
gradient formation of BMP in Drosophila41. Furthermore, type IV collagen activates 
integrin signaling to enhance levels of pMAD (phosphorylated MAD (R-Smad)) leading 
to increased BMP signaling. Drosophila embryos have a disrupted BMP response in 
absence of integrin, which binds to BMP receptors and promotes pMAD levels post BMP 
receptor activation. Lastly, α-integrin is activated in a positive feedback loop by BMP161.  
 The relevance of interactions of growth factors and the ECM is best characterized 
by studies on Marfan Syndrome. Mutations in fibrillin-1, which binds LAP, lead to 
symptoms such as tall stature, and aortic dilations162. Mutations leading to decrease in 
fibrillin-1 are directly related to an increase in TGF-β levels. In mouse models, 
alleviation of Marfan symptoms is seen with inhibition of TGF-β163. Alterations in ECM-
TGF-β interactions are observed in multiple diseases, associated with an increase in 
TGF-β levels. Most intriguingly, in Osteogenesis Imperfecta (OI), which results from 
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type I collagen mutations, an increased was observed in TGF-β and pSMAD2 
(phosphorylated Smad 2) levels. Inhibition of TGF-β via 1D11 antibody led to 
improvements in mouse model of OI116.  
In C. elegans, interactions between TGF-β signaling and ECM interactions have 
not been thoroughly explored. A homolog of fibrillin-1, FBN-1 in C. elegans cannot 
interact with the BMP homolog DBL-1. fbn-1 mutants have a detached pharynx164. A 
second homolog of fibrillin-1, MUA-3 has been shown to have a genetic interaction with 
DBL-1165 but the exact nature of this interaction is still unclear. I have previously shown 
that cuticle collagen genes act as effectors of body size regulation via the DBL-1 pathway 
in C. elegans. The cuticle is a collagenous extracellular matrix prompting us to ask 




IV.2.1 Does cuticle integrity affect DBL-1 signaling? 
I utilized the RAD-SMAD strain to investigate changes in DBL-1 signaling under RNAi 
of col-41, rol-6, col-141, and col-142.  The RAD-SMAD reporter strain contains nuclear 
localized GFP driven by a promoter region28 containing multiple Smad Binding Elements 
(SBE); it has been previously shown to respond to changes in DBL-1 signaling 
appropriately. sma-2 RNAi was used as a positive control and L4440 was used as the 
empty vector control. In the hypodermis, at the L4 stage, col-41i and col-141i resulted in 
an increase in RAD-SMAD GFP expression; meanwhile rol-6i and col-142i resulted in a 
decrease. At the adult stage, rol-6i, col-141i, and col-142i resulted in a decrease in GFP 
expression while col-41i did not have a significant change in expression (Fig.1). Except 
for col-41 at the adult stage, RNAi of other collagens led to changes in RAD-SMAD 
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signaling, hence changes in cuticle integrity can influence DBL-1 signaling activity. The 
RAD-SMAD reporter has peak activity in the L3 and L4 stage; additional trials should be 
conducted at L3, L4 and adult stage before drawing further conclusions.  
 
IV.2.2 Effects of compromising cuticle integrity on DBL-1 ligand distribution 
Based on preliminary data with the RAD-SMAD reporter, which showed changes in 
DBL-1 signaling under RNAi of col-41, rol-6, col-141 and col-142, I asked whether these 
changes were due to changes in DBL-1 ligand distribution. We collaborated with Dr. 
Tina Gumienny (Texas Woman’s University), Dr. Gumienny provided a strain containing 
DBL-1::GFP fusion, this reporter can be used to observe presence of intracellular DBL-1. 
We crossed this translational reporter into a rol-6 (e187n1270) null mutant background.   
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Figure 1: Cuticle Collagen RNAi of RAD-SMAD Reporter. A: RAD-SMAD activity in the intestine at 
L2 stage. B: RAD-SMAD activity in the hypodermis at L4 and adult stage. * P < 0.05, ** P < 0.005, *** P 
< 0.0005 
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Dr. Gumienny’s imaging of adult DBL-1::GFP in a rol-6 null mutant background 
displayed changes in distribution, although they were not statistically significant (Fig. 2). 
To further investigate, RNAi of col-41, rol-6, col-141 and col-142 was performed on the 
DBL-1:GFP translational reporter strain. RNAi results indicated a significant decrease in 
intracellular DBL-1::GFP, under all four RNAi conditions (Fig. 2). With the exception of 
col-41 RNAi, RNAi of other cuticle collagens showed a decrease in RAD-SMAD 
expression at the adult stage (Fig. 1B), analogous to DBL-1::GFP RNAi results. Whether 
these changes were the result of DBL-1 degradation, or changes in transcription was 
unclear. Henceforth, we utilized a transcriptional reporter to investigate if changes in 
localization were due to a decrease in expression. 
  
Figure 2. DBL-1::GFP Localization Is Affected By Cuticle Collagen RNAi. RNAi inhibition of col-41, 
rol-6, col-141, and col-142 led to a decrease in DBL-1::GFP localization. rol-6(e187n1270);dbl-1::gfp did 
not show significant changes in localization. * P < 0.05, ** P < 0.005, *** P < 0.0005  
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Figure 3: dbl-1 Transcription Is Affected In Cuticle Collagen Mutants. A: pdbl-1::gfp;rol-
6(e187n1270) has loss of GFP expression in rol-6 null mutant background.  
 
 
2.3 dbl-1 transcription is affected in a rol-6 null mutant background 
In order to investigate if changes in intracellular DBL-1, as observed with the 
DBL-1::GFP translation reporter; were due to changes in dbl-1 transcription we used 
pdbl-1::gfp transcriptional reporter. I crossed this strain into a rol-6 null mutant 
background and observed complete loss of GFP expression at all stages (Fig. 3), this 
strongly indicates that compromising cuticle integrity can affect DBL-1 signaling. To 
further verify this result we also crossed pdbl-1::gfp transcriptional reporter into the 
col-141(lf[2xnls::gfp]) transcriptional reporter created via CRISPR-Cas9 (pending 
result). Lastly, I will further verify changes in transcription in cuticle collagen mutant 
strains via qRT-PCR to measure transcript levels of dbl-1.  
III. 3 Discussion and Future Directions 
We previously showed that cuticle collagens are the effectors of body size 
regulation via the DBL-1 pathway. I wanted to investigate whether changes in cuticle 
composition due to defects in cuticle collagen genes led to downstream changes in 
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DBL-1 signaling. Our DBL-1::GFP localization data and rol-6 (e187n1270);pdbl-1::gfp 
data indicates changes in DBL-1 localization due to dbl-1 transcription because of 
changes in cuticle composition. Electron microscopy performed on 2-day old adult sma-3 
mutants shows a detached and indented cuticle phenotype (Fig. 4). This led me to 
speculate that perhaps the changes in dbl-1 transcription are due to changes in how 
physical pressure is applied on the nematode leading to downstream changes in gene 
expression. 
 
Figure 4: Altered Cuticle Morphology In sma-3 Mutants. Cross section EM of 2-day old adults. In sma-
3 mutants the cuticle is detached and there are rough indentations relative to wild type.  
 
There are multiple examples of changes in gene expression due to changes in 
physical stress and pressure applied on an organism. Harada et al (2016), showed that 
changes in physical stress on C. elegans causes a change in body size due to changes in 
dbl-1 expression. C. elegans cultured in microgravity were small with low levels of dbl1; 
restoration of gravity by centrifugal force led to normal body size and normal dbl-1 
levels166. Furthermore, mechanical pressure on plasma membrane in osteoblasts inhibits 
endocytosis of BMP2 and increases nuclear localization of Smads167,168. In Drosophila 
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embryos, mechanical pressure for 5 minutes induced twist, a transcription factor critical 
in early gastrulation and necessary for mesoderm invagination169. Lastly, there are 
examples of collagen mutations leading to an increase in TGF-β signaling in osteogenesis 
imperfecta (OI)116. Knockdown of TGF-β leads to alleviation of OI symptoms in mice, 
although a mechanism has not been established. We observe a similar change in our work 
whereby collagen mutations likely lead to changes in DBL-1 levels, hence C. elegans can 
serve as an excellent model system for rapidly exploring a mechanism and possible 
treatments for OI.  
Since we observed changes in dbl-1 transcription via a dbl-1 transcriptional 
reporter, I wanted to investigate a possible mechanism of changes in cuticle integrity 
leading to changes in dbl-1 expression. The cuticle is attached to the hypodermis of the 
worm via fibrous organelles, which are structures found in the underlying hypodermal 
cells underneath the body wall muscles and help link the hypodermis and the cuticle. 
Fibrous organelles contain hypodermal hemidesmosomes, found on the apical and basal 
side of the hypodermis. Interacting with the hemidesmosomes is a complex of MUA-3 
(fibrillin-1 homolog), MUP-4 and MUA-6 (homolog of intermediate filaments). 
GFP::SMA-3 ChIP-seq identifies the genomic region of mua-3 as a site of Smad binding. 
MUA-3 localizes with cytoplasmic intermediate filaments (IF) and links the IF 
cytoskeleton of the hypodermis to the cuticle170. It is possible that changes in the fibrous 
organelle complex could alter how physical stress required for proper growth and normal 
body size. I would investigate changes in MUA-3, MUP-4, and MUA-6 localization in 
rol-6 (e187n1270) null mutants and in col-141 (lf) mutants using translational reporters of 
MUP-4 and MUA-6 and using an antibody for MUA-3. It’s possible that detachment of 
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the cuticle in dbl-1 mutants is due to changes in expression of MUA-3 in absence of 
DBL-1 signaling; therefore, I will perform qRT-PCR to confirm MUA-3 as a 
transcriptional target of the DBL-1 pathway.  
One of the ways in which physical pressure and stress is relayed is through the 
actin cytoskeleton of the cell. There are bundles of actin filaments underlying the cuticle 
furrows, these actin bundles help tether the cuticle to the hypodermis and body wall 
muscle. Investigating changes in organization of actin in rol-6 (e187n1270) null mutants 
and in col-141 (lf) mutants via Rh-phalloidin (a bicyclic peptide that binds actin with high 
selectivity) staining would further help characterize downstream effects of compromising 
cuticle integrity.  
	   	  















CONCLUSION   
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The regulation of body size through DBL-1 signaling involves tissue crosstalk, 
master transcription factors, and cuticle collagen genes acting as effectors of body size. 
DBL-1 signaling is a major regulator of body size in C. elegans. Loss of function dbl-1 
mutants are small. It was previously established that the presence of SMA-3 in the 
hypodermis is necessary and sufficient for normal body size54. However, the effector 
genes of body size regulation had not been identified. Therefore, we investigated the 
transcriptional network of genes involved in body size regulation. To that effect we 
discovered that the cuticle collagen genes are hypodermal-specific transcriptional targets 
of DBL-1 signaling that can regulate body size as positive, negative and dose-sensitive 
regulators. In Yin et al. we showed that col-41, a positive regulator of body size is 
regulated by elt-1, a hypodermal GATA factor121 that is a master transcription factor 
(MTF) and determines hypodermal cell fate.  
We further established that col-41 is an indirect target and col-141 and col-142 
are direct targets of DBL-1. Which DBL-1-responsive transcription factor directly 
regulates col-41 gene expression is unknown. A yeast one-hybrid approach which utilizes 
a bait sequence upstream of a Gal-4 promoter::LacZ reporter and a C. elegans protein 
library can be used to identify transcription factors responsible for col-41 expression. I 
have shown via SMA-3::GFP ChIP-Seq that col-141 and col-142 are directly regulated 
by Smad binding in a common regulatory region (col-p). I showed SMA-4 binding to 
conserved SBEs in col-p; however, SMA-2 and SMA-3 did not bind to these sequences. I 
further showed that col-p drives gene expression under DBL-1 pathway regulation. Based 
on accomplished work, it is likely that Smad binding in col-p regulates both col-141 and 
col-142. An additional experiment to further establish that Smads directly regulate 
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col-141 and col-142 would be via mutations of sites 3 and 4 generated utilizing CRISPR-
Cas9, at their endogenous location in the genome.  
 
 
Figure 1: Body size regulation via the DBL-1 pathway. ELT-1 is a MTF required for 
hypodermal cell fate, ELT-3 maintains hypodermal cell fate after ELT-1 is no longer 
expressed.  
 
 Zhang et al.24 have shown that MTFs can recruit Smads to bind DNA for gene 
regulation. Since MTFs differ for each cell type, the study of MTFs can provide insights 
into tissue specific gene profiles induced by the same signaling pathway. elt-1 is 
necessary and sufficient for hypodermis cell fate and hence qualifies as an MTF141. We 
were further interested in exploring how DBL-1 signaling achieved context dependent 
gene regulation in multiple tissues. To that end I performed RNAi of hypodermal specific 
(elt-1) and intestinal specific (elt-2) MTFs and measured transcript levels of hypodermal 
specific and intestinal specific genes, however, the data did not provide insights into 
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tissue specific regulation of targets of DBL-1 signaling. RNAi knockdown of elt-1 and 
elt-2 in transcriptional reporters of genes that are hypodermal and intestinal specific 
targets of the DBL-1 signaling, can provide further insight. Alternatively, ChIP-sequence 
analysis of elt-1 and elt-2 would provide candidate genes directly bound by MTFs. A 
cross check against GFP::SMA-3 ChIP-Seq data would provide target genes bound both 
by MTFs and Smads.  
Although presence of SMA-3 in the hypodermis is necessary and sufficient for 
normal body size, there are intestinal specific transcriptional targets of DBL-1 (zip-10, 
bZIP transcription factor) that regulate body size. This indicates that there is crosstalk 
between the hypodermis and the intestine suggesting cell non-autonomous regulation of 
body size. It is possible that the hypodermis releases ligands that can initiate signaling in 
the intestine to regulate intestinal genes relevant for normal body size. To that end, we 
used strains with tissue specific expression of SMA-3 and measured the transcript levels 
of several hypodermal and intestine specific genes in each strain, however the data did 
not provide insights. This strongly suggests an alternative approach is required to 
investigate cell autonomous and cell non-autonomous behavior of Smads and tissue 
crosstalk. The use of transcriptional reporters of hypodermal and intestinal genes crossed 
into the tissue specific strains would be a better approach.  
How does the worm feel changes in physical pressure and how does that cause 
changes in body size? DBL-1 is released from the ventral nerve cord (VNC) (Figure 2A) 
and diffuses to reach cells where the receptors and signal transducers of the pathway are 
present. DBL-1 secretion from the VNC can easily target the adjacent hyp7 syncytium, a 
critical tissue for body size regulation. However, it has been established that the source of 
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DBL-1 is not relevant, if DBL-1 is present it will reach the target tissues. On each side of 
the worm are two external structures on the cuticle composed of cuticle collages called, 
alae (Figure 2), these structures are only present in the L1 and adult stage of the worm. 
Knockdown of cuticle collagens such as col-19, a non-essential cuticle collagen, disrupts 
the structure of the alae 171. It’s thought that the alae are used for traction for locomotion. 
At each larval stage the composition of the cuticle changes due to the expression of stage 
specific cuticle collagens, it is plausible that the alae are the result of the properties of 
cuticle collagens expressed only at the L1, dauer, and adult stage. The L1, dauer, and 
adult stage have the slowest growth, likely due to stage specific cuticle collagens that 
limit the flexibility of the cuticle to allow for more growth and the alae as part of that 
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Figure 2: Nematode body plan with cross sections from head to tail. The 
approximate level of each cross section is labeled in IntroFIG 1B. Orange lines indicate 
basal laminae. A. Posterior body region. Body wall (outer tube) is separated from the 
inner tube (alimentary system, gonad) by a pseudocoelom. B. Section through anterior 
head. The narrow space between the pharynx and the surrounding tissues anterior to the 
NR can be considered an accessory pseudocoelom because the main pseudocoelom is 
sealed off by the GLRs at the NR level. C. Section through the middle of head. D. 
Section through posterior head. E. Section through posterior body. (DNC) Dorsal nerve 
cord; (VNC) ventral nerve cord. F. Section through tail, rectum area. 
 
 
Preliminary data with RAD-SMAD reporter and dbl-1 transcriptional reporter, 
suggests that changes in rigidity/flexibility of the cuticle can alter DBL-1 levels, the 
mechanism for this affect is unclear. It has been shown that the worm grows in a 
continuous manner within each larval stage and must reach a size threshold before 
molting and proceeding to the next larval stage and growth is continuous within each 
larval stage 172. The biggest increase in size is observed in the L3 and L4 stage, this 
coincides with the peak of DBL-1 activity as observed by the RAD-SMAD reporter. 
However, this growth rate can be altered based on food availability, such that low food 
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availability will lead to a slower growth rate and longer time spent in that larval stage. 
Nonetheless, the worm must meet a size threshold before proceeding to the next stage 
even under low food availability. It’s likely that the worm must grow completely within 
the present cuticle before molting and formation of a new longer or more flexible cuticle 
to allow for further growth and increase in body size. Henceforth, altering the 
composition of the cuticle via collagen mutants can decrease or increase the 
flexibility/rigidity of the worm allowing for increased or decreased growth in each larval 
stage. In sma-3 mutants, the rate of growth within each larval stage is slower compared to 
wild type worms. In absence of dbl-1 signaling, the cuticle composition is altered due to 
changes in expression of multiple cuticle collagens and that in turn changes the 
flexibility/rigidity of the cuticle which alters the growth rate and affects the final body 
size.  
In humans, collagens constitute ~30% of the protein mass and are the most 
abundant protein. Collagens function in a diverse range of processes such as mechanical 
properties of tissues, ligands for receptors, cell growth, differentiation, cell migration, 
bone formation, skeletogenesis, and the integrity and function of the epidermis 71-73. The 
expression levels of collagens must be tightly controlled during wound healing, and 
inappropriate expression of collagens can lead to fibrosis 114,115. Mutations in collagens 
have been recognized in rare heritable diseases such as osteogenesis imperfecta, several 
subtypes of Ehlers-Danlos syndrome, various chondrodysplasias, X-linked forms of 
Alpoty syndrome, Ullrich muscular dystrophy, corneal endothelial dystrophy, and 
Knobloch syndrome 76. Collagen mutations as seen in osteogenesis imperfecta can result 
in increased TGF-β signaling 116. Identifying components of the regulatory network in 
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collagen gene expression can lead to potential new drug targets for collagen related 
diseases.   
Collagen mutations in diseases lead to lack of collagen but can also lead to 
accumulation of defective collagens that can lead to symptoms, identifying drugs, which 
affect the mutant collagens, can potentially produce therapies in these diseases. C. 
elegans can be used as a model for drug-discovery. Collagen mutant worms in a drug 
screen against a chemical library (for instance, using col-141 mutant reporter worms) can 
be used to identify molecules that cause changes in collagen levels. Collagens and their 
regulation have significant implications for human health. Our work further adds to the 
functional importance of collagens in the context of growth regulation. 
Lastly, my work offers the first evidence of collagens regulating BMP signaling 
in C. elegans. Preliminary data utilizing a transcriptional reporter in rol-6 null mutant 
background establishes an effect on DBL-1 signaling due to changes cuticle integrity. 
Further work characterizing changes downstream of the cuticle and a possible mechanism 
is required. Nonetheless, we see a bidirectional effect, where DBL-1 signaling regulates 
cuticle composition and changes in cuticle integrity leads to regulation of DBL-1 
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Unpublished EMSA data for SMA-2, SMA-3, & SMA-4 binding to col-p and col-41 
regulatory region. 
 
Element 1: 1389-1423 
aaggtatactgaatatccgtcgcattgcga 
 
Element 2: 1239-1282 
tatagataacataaacagtggagtggataa 
 
Element 3: 1190-1217 
tcgaatcggcatctctgcgcacttctcctc 
 
Element 5: 449-505 
tagctttaGTCTagtttagttaagttcaac 
 




1) SMA-2/col-41 EMSA 
 
 
Gel –dI/dC From Left- 1: E1 probe only; 2: E1+SMA-2; 3: E2; 4: E2+SMA-2; 5: E3 
only; 6:E3+SMA-2; 7: E6 only; 8:E6+SMA-2; 9: Race Probe only; 10:Race+SMA-2 11: 











2) SMA-2/col-41 EMSA 
 
 
Gel +dI/dC From Left- 1: E1 probe only; 2: E1+SMA-2; 3: E2; 4: E2+SMA-2; 5: E3 
only; 6:E3+SMA-2; 7: E6 only; 8:E6+SMA-2; 9: Race Probe only; 10:Race+SMA-2 11: 
















3) SMA-3/col-41 EMSA 
 
 
From Left- 1:Probe only 2: Probe +Positive control; 3: E1 probe only; 4: E1+SMA-3; 5: 
E2 probe only; 6: E2+SMA-3; 7: E3 only; 8:E3+SMA-3; 9: E5 probe only; 10: 
E5+SMA-3; 11: E6 only; 12:E6+SMA-3; 13: Race Probe only; 14: Race+SMA-3;        

















4) SMA-3/col-41 EMSA 
 
 
From Left- 1:Probe only 2: Probe +Positive control; 3: E1 probe only; 4: E1+SMA-3; 5: 
E2 probe only; 6: E2+SMA-3; 7: E3 only; 8:E3+SMA-3; 9: E5 probe only; 10: 
E5+SMA-3; 11: E6 only; 12:E6+SMA-3; 13: Race Probe only; 14: Race+SMA-3;        
















































6) SMA-3 col-p probes and SMA-4/col-41 probes 
 
 
col141/142 probes Lanes 1-3: probe 1, 1+SMA-3, 1+SMA-4 respectively. Lanes 4-6 are 
probe 2, 2+SMA-3, 2+SMA-4. Lanes 7-9: probe 3, 3+SMA-3, 3+SMA-4 respectively.  
Lanes 10-12: probe 4, 4+SMA-3, 4+SMA-4 respectively.  
col-41 probes, Lanes 13-14: E1, E1+SMA-4; Lanes 15-16: E3, E3+SMA-4; Lanes 17-18: 






















7) Competition Assay using cold mutant 3 probes 
 
 
col141/142 probes Lanes 1-2: probe 3, 3+SMA-34. Lanes 3-7: 3+SMA-4+ cold mutant 3 























8) Competition Assay with cold mutant probe 4 
 
 
Probe 4:    ggtgAGACaagcaatgagaatAGACacaca 

















9) Mutant probe 3 and 4/SMA-4 
 
 
col141/142 probes Lanes 1-2: probe 3, 3+SMA-4. Lanes3-4 : 4, 4+SMA-4 
Lanes 5-8: replicates of lanes1-4 






















10) Competition Assay for cold mutant probes 3 and 4 
 
 
col141/142 probes Lanes 1-2: 4, 4+SMA-4; 3: sm1+ SMA-4; 4: sm2+SMA-4; 5: 
m4+SMA-4; 6-8:4+c4 5x, 10x, 80x.  Lanes 9-11: 4+SMA-4+ cold mutant 4 at 5x, 10x, 














11) Single Mutations for Probe 4 
 
 
Probe 4:    ggtgAGACaagcaatgagaatAGACacaca 
SM1:         ggtgAGATaagcaatgagaatAGACacaca 
SM2:         ggtgAGACaagcaatgagaatAGATacaca 
















12) Comeptition Assay single mutations in Probe 4 and cold Mutant  
 
 
Probe 4:   ggtgAGACaagcaatgagaatAGACacaca 
SM1:         ggtgAGATaagcaatgagaatAGACacaca 
SM2:         ggtgAGACaagcaatgagaatAGATacaca 














13) SMA-4 dilution gel 
 
 
1: probe 3; 2: 3+SMA-4; 3: 3+SMA-4 (5x diluted); 4: 3+SMA-4 (20x diluted); 5:4;            
6: 4+SMA-4; 7: 4+SMA-4 (5x diluted); 8: 4+SMA-4 (20x diluted) ; 9: mutant 4; 10: 
m4+SMA-4; 11: m4+SMA-4 (5x diluted); 12: m4+SMA-4 (20x diluted) 
 
 
